Intrinsiqq
Werewolf Therapeutics, Inc. logo

Werewolf Therapeutics, Inc.

HOWL

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$46M
EPS-$0.59
P/E-1.60
P/FCF-1.92
EV/EBITDA-0.16
FCF Yield–
Div. Yield–
Net Debt/FCF1.7x
Werewolf Therapeutics, Inc. intrinsic value
52-Week Range
$0.31$1.10

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$28M

▲ +13.7% YoY

Op. Margin

–

ROIC

-40.52%

▼ -4.9pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$24M

▼ -6.8% YoY

Op. Cash Flow (TTM)

-$24M

▼ -7.3% YoY

Net Debt

-$42M

Net Cash Position

Cash & Equiv.

$42M

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with HOWL

CompareIntrinsic value
KTTAPasithea Therapeutics Corp.
$0.48-0.48%40
TPSTTempest Therapeutics Inc.
$0.29-5.36%0
PCSAProcessa Pharmaceuticals Inc.
$1.56-7.69%10
CPIXCumberland Pharmaceuticals Inc.
$5.84-7.30%20
GRIGri Bio Inc.
$1.12+0.00%20
PSTVPlus Therapeutics Inc
No recent price20
EVFMEvofem Biosciences Inc.
$1.00+0.00%15
MBRXMoleculin Biotech Inc.
$7.74-2.40%20

Werewolf Therapeutics (HOWL) in two numbers

Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-1.60
Negative: a loss over the last twelve months. Price to free cash flow -1.92.
Financials

Questions about Werewolf Therapeutics

Does Werewolf Therapeutics (HOWL) pay a dividend?

No. Werewolf Therapeutics (HOWL) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 9 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in HOWL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing HOWL

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.